Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Ligand Pharmaceuticals
Business Segments
Products & Services
Asset impairment charges
Asset impairment charges
Ligand Pharmaceuticals
·
Products & Services
·
1 segment
·
Rolls up to
Impairment Charges
Breakdown
Segments
Captisol
View metric
Annual
Segment
FY'24
FY'25
Captisol
$0
$0
Total
$30.57M
$6.2M
All segment values are derived from annual filings.